Synthesis is honored to announce the addition of Dr. Rosalind Watts as the new Clinical Director, designing a retreat model with her research on psilocybin for treatment-resistant depression so Synthesis can lead the way for a new era of safe, legal and professional psychedelic experiences.
It is with a tender heart that we say a grateful goodbye to the home of our retreats for the last two years, the sacred space of The Lighthouse.
With gratitude and optimism, co-founder Martijn Schirp shares an announcement on his new role transition, as Rachel Aidan becomes CEO.
Synthesis welcomes Tero Isokauppila to support the strategy and development of our fast-growing psilocybin retreat startup. Read more here!
This DW documentary film features an inside look inside a Synthesis Retreat and follows the journey of a man who microdoses LSD, with life-changing results.
Rosalind Watts is the Lead Clinical Psychologist at Imperial College London’s Centre for Psychedelic Research, and has been pioneering research in the therapeutic potential of psilocybin.
Synthesis welcomes neuroscientist Dr. Robin Carhart-Harris to support the strategy, research, and development of our fast-growing psilocybin retreat start-up. Find out more about how his